The concomitant use of oxycodone hydrochloride tablets and CYP3A4 inducers can reduce the plasma concentration of oxycodone [see Scientific Pharmacology (12.In all clients for whom dosing information was offered (n=191) with the open-label and double-blind experiments involving oxycodone hydrochloride tablets, the following adverse activities had